Euro vs US Dollar

Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.

Registrieren

SYRS Syros Pharmaceuticals Inc

5,20

0,00 (0,00%)

Vor Marktöffnung

Zuletzt aktualisiert: 10:00:00

Verzögert um 15 Minuten

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Article too big to display. Click here to view on the SEC website

Syros Pharmaceuticals (NASDAQ:SYRS)
Historical Stock Chart
Von Apr 2024 bis Mai 2024

Click Here for more Syros Pharmaceuticals Charts.

Syros Pharmaceuticals (NASDAQ:SYRS)
Historical Stock Chart
Von Mai 2023 bis Mai 2024

Click Here for more Syros Pharmaceuticals Charts.

News Syros Pharmaceuticals Inc

Syros Receives Fast Track Designation from the FDA for Tamibarotene for the Treatment of Newly Diagnosed Unfit AML with RARA gene overexpression
Dienstag 9 April 2024 (3 Wochen vor) • Business Wire

Syros Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Dienstag 2 April 2024 (1 Monat vor) • Business Wire

Syros Reports Fourth Quarter and Full Year 2023 Financial Results and Provides a Corporate Update
Mittwoch 27 März 2024 (1 Monat vor) • Business Wire

U.S. Stock Index Futures Point to a Rebound, Oil See Declines in Early Trading
Mittwoch 27 März 2024 (1 Monat vor) • IH Market News

Syros Announces Completion of Enrollment of 190 Patients Necessary to Support Primary Endpoint Analysis in SELECT-MDS-1 Phase 3 Trial
Montag 25 März 2024 (1 Monat vor) • Business Wire

Syros to Report Fourth Quarter and Full Year 2023 Financial Results on Wednesday, March 27, 2024
Mittwoch 20 März 2024 (1 Monat vor) • Business Wire

Syros to Participate in TD Cowen 44th Annual Health Care Conference
Dienstag 27 Februar 2024 (2 Monate vor) • Business Wire

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
Donnerstag 15 Februar 2024 (3 Monate vor) • Edgar (US Regulatory)

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Mittwoch 14 Februar 2024 (3 Monate vor) • Edgar (US Regulatory)

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Mittwoch 14 Februar 2024 (3 Monate vor) • Edgar (US Regulatory)

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Mittwoch 14 Februar 2024 (3 Monate vor) • Edgar (US Regulatory)

Form 8-K - Current report
Montag 8 Januar 2024 (4 Monate vor) • Edgar (US Regulatory)

Weitere Syros Pharmaceuticals Inc News-Artikel

Health Care Select Sector

Deutsche Telekom

Euro vs Sterling

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen